Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Santoro, Armando, MD, Rimassa, Lorenza, Dr, Borbath, Ivan, MD, Daniele, Bruno, MD, Salvagni, Stefania, MD, Van Laethem, Jean Luc, Prof, Van Vlierberghe, Hans, MD, Trojan, Jörg, Prof, Kolligs, Frank T, Prof, Weiss, Alan, Prof, Miles, Steven, MD, Gasbarrini, Antonio, Prof, Lencioni, Monica, MD, Cicalese, Luca, MD, Sherman, Morris, MD, Gridelli, Cesare, MD, Buggisch, Peter, MD, Gerken, Guido, Prof, Schmid, Roland M, Prof, Boni, Corrado, MD, Personeni, Nicola, MD, Hassoun, Ziad, MD, Abbadessa, Giovanni, MD, Schwartz, Brian, MD, Von Roemeling, Reinhard, MD, Lamar, Maria E, BA, Chen, Yinpu, PhD, Porta, Camillo, MD
Published in The lancet oncology (2013)
Published in The lancet oncology (2013)
Get full text
Journal Article